Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bagsvaerd Denmark
- Most recent report
- 6-K, filed Aug 18, 2026
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 353278
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 903
- 6-K Report a foreign issuer made public elsewhere Aug 18, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 10, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 10, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 4, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 4, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 4, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 31, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 27, 2026
Prospectuses and Registrations 3
Ownership 8 of 20
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jun 22, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 10, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Mar 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 21, 2025
- 144 Notice of a proposed sale of restricted stock May 30, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 23, 2025
- SC 13G/A Large holder reported a passive stake, amended Feb 6, 2024
- SC 13G/A Large holder reported a passive stake, amended Feb 23, 2023
Other 8 of 74
- 11-K Employee stock plan report Jun 22, 2026
- 11-K Employee stock plan report Jun 22, 2026
- SD Conflict minerals disclosure May 22, 2026
- IRANNOTICE Notice of Iran-related activity Feb 4, 2026
- 11-K Employee stock plan report Jun 27, 2025
- 11-K Employee stock plan report Jun 27, 2025
- SD Conflict minerals disclosure May 22, 2025
- IRANNOTICE Notice of Iran-related activity Feb 10, 2025
Everything here comes from Novo Nordisk A S's own filings on SEC EDGAR. The filing list is rechecked every hour.